Please select an option below to help us tailor your newsletter to best suit your content interests!
Lung Cancer: Chaired by Jason Porter, MD Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of lung cancer. Speakers: Jason Porter, MD | West Cancer Center & Research Institute Wade T. Iams, MD… Read more »
West Cancer Center & Research Institute welcomes three distinguished physicians as partners of the cancer center West Cancer Center & Research Institute is governed by a physician partnership to ensure care for cancer patients is clinically superior with the latest technology and research. Matthew Ballo, MD, FACR, Richard Fine, MD, FACS and Eric Wiedower,… Read more »
West Cancer Center & Research Institute’s Michael G. Martin, MD, has been recognized by the distinguished International Journal of Molecular Sciences for a publication of high impact based on views and downloads. West Cancer Center & Research Institute is home to more than 100 oncology/hematology specialists with 1000+ publications in numerous esteemed medical journals…. Read more »
The 6th Annual West Oncology Conference will serve as a valuable forum for the presentation and discussion of new research findings. Participants will be provided with an update on practice-changing data on women’s cancers, genitourinary malignancies, disparities in cancer care, gastrointestinal cancers, hematological malignancies, and lung cancer in a practical and interactive format, fostering discussion… Read more »
2020 Top Stories in Advanced Melanoma: Drastic Improvement in Melanoma Mortality With Novel Agents Written by Ari VanderWalde MD, MPH, FACP Despite a plethora of interesting findings and results of novel clinical trials in melanoma in 2020, I believe the most important story of the year was actually a small, easy-to-overlook, 3-page report in the American… Read more »
Axel Grothey, MD, medical oncologist and our Director of Gastrointestinal Cancer Research, discusses the role of precision medicine in colorectal cancer (CRC) with OncLive. Grothey says, “With the rise of molecular profiling, the field of CRC has shifted away from a one-size-fits-all approach and entered an era of precision medicine. Notably, molecular profiling guides the… Read more »
Lee S. Schwartzberg, MD, of the West Cancer Center, discusses phase III results from the CONTESSA study, which showed that an all-oral regimen of tesetaxel plus a reduced dose of capecitabine significantly improved progression-free survival compared with capecitabine alone in patients with HER2-negative, hormone receptor–positive metastatic breast cancer previously treated with a taxane (Abstract GS4-01)…. Read more »
Ari VanderWalde, MD, MPH, Bioeth, West Cancer Center and Research Institute’s Director of Research, stands behind the safety and highly regulated protocols for participants in clinical trials. Dr. VanderWalde recognized the importance and urgency to create a safe and effective vaccine to combat COVID-19. “I had a 50% chance of getting the vaccine and 50%… Read more »
West physicians Dr. Ari VanderWalde, Dr. Axel Grothey, Dr. Daniel Vaena, Dr. Gregorgy Vidal, Dr. Adam ElNaggar, & Dr. Lee Schwartzberg recently published a study on the establishment of a Molecular Tumor Board & Uptake of Recommendations in a Community Setting. Abstract In the precision medicine era, molecular testing in advanced cancer is foundational… Read more »
Gregory Vidal, MD, PhD, West Cancer Center and Research Institute, discusses the methodology of the Neat-HER study on neratinib in the extended adjuvant setting in HER2-positive breast cancer. Gregory Vidal, MD, PhD, of West Cancer Center and Research Institute, discusses the methodology of the Neat-HER study on neratinib in the extended adjuvant setting in… Read more »